|

Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

RECRUITINGN/ASponsored by OHSU Knight Cancer Institute
Actively Recruiting
PhaseN/A
SponsorOHSU Knight Cancer Institute
Started2022-10-31
Est. completion2026-09-30
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
Locations4 sites
View on ClinicalTrials.gov →

NCT05407168

Summary

This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.

Eligibility

Age: 18 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

* AIM 1: Suspected lung cancer
* AIM 1: English fluency
* AIM 1: \> 6-month life expectancy
* AIM 1: Score of ≥ 3 on the cognitive impairment screener
* AIM 2 PARTICIPANTS: Participation in Aim 1
* AIM 2 CLINICIANS: Discussing lung cancer treatment decisions with Aim 1 participants

Conditions3

CancerLung CancerLung Carcinoma

Locations4 sites

Hillsboro Medical Center
Hillsboro, Oregon, 97123
Donald Sullivan, MD, MA, MCR503-220-8262sullivad@ohsu.edu
Adventist Health Portland
Portland, Oregon, 97216
Donald Sullivan, MD, MA, MCR503-220-8262sullivad@ohsu.edu
OHSU Knight Cancer Institute
Portland, Oregon, 97239
Donald R Sullivan, MD, MA, MCR503-220-8262sullivad@ohsu.edu
Portland VA Medical Center
Portland, Oregon, 97239
Donald R Sullivan, MD, MA, MCR503-220-8262sullivad@ohsu.edu

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.